UPB Latest Press Releases

-- August 11, 2026 --

Upstream Bio Reports Second Quarter 2026 Financial Results and Highlights Continued Progress Globe Newswire 7:00 AM

-- June 14, 2026 --

Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026 Globe Newswire 10:00 AM

-- June 8, 2026 --

Upstream Bio to Showcase Additional Efficacy Data from the Phase 2 VIBRANT Trial of Verekitug in CRSwNP in Oral Session at EAACI 2026 Globe Newswire 7:00 AM

-- June 3, 2026 --

Upstream Bio to Present at the Goldman Sachs 47th Annual Global Healthcare Conference Globe Newswire 7:00 AM

-- May 18, 2026 --

Upstream Bio Presents New Data from Phase 2 VIBRANT Trial of Verekitug Demonstrating Improvement in Asthma Symptom Control in Participants with CRSwNP and Comorbid Asthma at the ATS 2026 International Conference Globe Newswire 11:30 AM

-- May 13, 2026 --

Upstream Bio Reports First Quarter 2026 Financial Results and Recent Business Highlights Globe Newswire 7:00 AM

-- April 17, 2026 --

Upstream Bio to Present New Data from Phase 2 VIBRANT Trial of Verekitug at the ATS 2026 International Conference Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software